What is the most common cause of hair loss in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Cause of Hair Loss in Women

Androgenetic alopecia (female pattern hair loss) is the most common cause of hair loss in women, affecting approximately 50% of women over their lifetime and up to 40% of healthy women by reproductive age. 1, 2

Understanding Androgenetic Alopecia

Androgenetic alopecia is caused by androgens in genetically susceptible women, with dihydrotestosterone (DHT) binding to androgen receptors in hair follicles, causing progressive miniaturization of terminal follicles. 3 The condition typically presents with:

  • Diffuse thinning over the mid-frontal and parietal scalp with preservation of the frontal hairline 3, 4
  • Retention of occipital scalp density 3
  • Presence of miniaturized hairs within follicular units 4
  • Onset typically between ages 12-40 years with polygenic inheritance 3

The key pathophysiologic difference in women compared to men is that women have significantly higher levels of cytochrome p-450 aromatase in frontal follicles, which partially protects against complete baldness—explaining why women develop diffuse thinning rather than complete baldness until very late stages. 3

Other Important Causes to Consider

While androgenetic alopecia is most common, several other conditions frequently cause hair loss in women:

Telogen Effluvium

  • Stress-induced shedding triggered by physiologic or emotional stressors (illness, surgery, childbirth, rapid weight loss) 5
  • Characterized by diffuse shedding without the miniaturization pattern seen in androgenetic alopecia 5

Alopecia Areata

  • Autoimmune condition causing patchy, non-scarring hair loss with characteristic exclamation mark hairs 5, 6
  • Associated with other autoimmune diseases in 20% of cases 5
  • 34-50% recover spontaneously within one year 5

Nutritional Deficiencies

  • Iron deficiency (low ferritin) is the most common nutritional deficiency worldwide causing chronic diffuse telogen hair loss 5
  • Vitamin D deficiency (<20 ng/mL) affects 70% of alopecia areata patients versus 25% of controls 5
  • Zinc deficiency impairs hair follicle function 5, 6

Diagnostic Approach

Most women with androgenetic alopecia have normal menses and pregnancies, and extensive hormonal testing is unnecessary unless signs of androgen excess are present. 3 The American Academy of Family Physicians recommends targeted testing only when specific clinical features suggest underlying pathology:

When to Order Laboratory Tests

  • Test for testosterone, SHBG, and consider PCOS evaluation only if signs of androgen excess exist (hirsutism, severe acne, irregular periods) 5
  • Check TSH to rule out thyroid disease 5, 6
  • Measure serum ferritin, vitamin D, and zinc levels to identify nutritional deficiencies 5, 6
  • Consider prolactin if hyperprolactinemia suspected 5

Clinical Diagnosis Features

  • Early age of onset with frontal/parietal thinning pattern and occipital preservation strongly suggests androgenetic alopecia 3
  • Dermoscopy can differentiate androgenetic alopecia from alopecia areata (which shows yellow dots and exclamation mark hairs) and telogen effluvium 5

Common Pitfalls to Avoid

Avoid ordering excessive laboratory tests when the clinical diagnosis of androgenetic alopecia is evident based on pattern and age of onset. 5 The diagnosis is primarily clinical in most cases. 3

Do not overlook the psychological impact—hair loss causes significant stress and reduced quality of life in women, who typically do not anticipate age-related hair loss unlike men. 4, 2 Assessment for anxiety and depression may be warranted. 5

Remember that baldness in women occurs only when all hairs within follicular units are miniaturized, which is a relatively late event—early intervention with treatment is most effective. 4

Treatment Considerations

Topical minoxidil is the only FDA-approved medication for promoting hair growth in women with androgenetic alopecia, with efficacy demonstrated in double-blind studies. 3 Other options include:

  • Antiandrogens (spironolactone, cyproterone acetate) and 5α-reductase inhibitors (finasteride) work best when initiated early 4, 1
  • Hair transplantation should be considered for advanced cases resistant to medical treatment, requiring well-preserved occipital donor area 4

References

Research

Androgenetic alopecia in women.

The journal of investigative dermatology. Symposium proceedings, 2003

Guideline

Hair Loss Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hair Loss Assessment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.